|
⚲
|
| Keyboard |
| Kenney Christopher John
✚
|
|
|---|---|
| CIK # | 0001880129 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001880129] | |
| 4 | [0001880129] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Xenon Pharmaceuticals Inc | |
| Kenney Christopher John |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-13 | Sell | 1,410 | $55.23 | 77,874 |
|
Xenon Pharmaceuticals Inc XENE
Restricted Share Units · derivative
|
2026-03-12 | Option exercise | 3,750 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-12 | Option exercise | 3,750 | ||
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-10 | Sell | 2,771 | $60.11 | 166,565 |
|
Xenon Pharmaceuticals Inc XENE
Performance Share Units · derivative
|
2026-03-09 | Option exercise | 7,500 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Performance Share Units · derivative
|
2026-03-09 | Grant | 7,500 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-09 | Option exercise | 7,500 | ||
|
Xenon Pharmaceuticals Inc XENE
Restricted Share Units · derivative
|
2026-01-09 | Grant | 20,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Share Option (Right to Buy) · derivative
|
2026-01-09 | Grant | 100,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Share Option (Right to Buy) · derivative
|
2025-03-12 | Grant | 80,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Restricted Share Units · derivative
|
2025-03-12 | Grant | 15,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2024-03-11 | Grant | 100,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2023-03-24 | Sell | 700 | $35.01 | 24,507 |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2023-03-10 | Grant | 120,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2022-03-10 | Grant | 125,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2022-01-21 | Buy | 700 | $28.81 | 20,167 |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2021-08-23 | Grant | 150,000 | $0.00 |